Click on there images to view there full Bios
2022 AAADV-ASCO-CDDF Program Committee
![](https://aaadv.org/wp-content/uploads/2021/08/Richard-L.-Schilsky-150x150.jpg)
Richard L. Schilsky, MD, FACP, FSCT, FASCO
Professor emeritus, University of Chicago
![](https://aaadv.org/wp-content/uploads/2019/01/Renzo_1486321795.jpg)
Renzo Canetta, M.D.
Independent Consultant, Former Head of Clinical Cancer Research, and Head of Regulatory Oncology Research Policy, Bristol Myers Squibb
![](http://aaadv.brad.blue:99/wp-content/uploads/2019/01/Thomas_1486324081.jpg)
Thomas Fleming, PhD
Professor Statistics, University of Washington
![](https://aaadv.org/wp-content/uploads/2021/07/Julie-Gralow-150x150.jpg)
Julie R. Gralow, MD, FACP, FASCO
Chief Medical Officer, American Society of Clinical Oncology (ASCO)
![](https://aaadv.org/wp-content/uploads/2021/03/unnamed-129x150.png)
Jaap Verweij, MD, PhD
Managing Director, Cancer Drug Development Forum
![Agnes Saint-Raymond](https://aaadv.org/wp-content/uploads/2022/07/Screen-Shot-2022-07-28-at-3.30.50-PM-150x150.png)
Agnes Saint-Raymond
Former EMA Head of the International Affairs Division
![](https://aaadv.org/wp-content/uploads/2019/01/H.-Kim_1473789997-2-150x150.jpg)
H. Kim Lyerly, MD, FACS, FSSO
George Barth Gellar Chair, Professor Surgery, Pathology and Immunology, Duke University
![](https://aaadv.org/wp-content/uploads/2019/11/Donald-Harvey-150x150.jpg)
Donald R. Harvey III, PharmD
Professor of Medical Oncology and Pharmacology, Emory University
2022 Pre-Workshop and In-Depth Discussion Group Program Committee
![](https://aaadv.org/wp-content/uploads/2019/05/Martin-Stockler-MBBS-e1686868203222-150x150.png)
Martin Stockler, MD
Professor of Oncology and Clinical Epidemiology, University of Sydney, Oncology Director at the NHMRC Clinical Trials Centre, University of Sydney
![](https://aaadv.org/wp-content/uploads/2019/05/Chitkala-Kalidas-e1686938951417-150x150.png)
Chitkala Kalidas, PhD
Vice President and Head of Global Regulatory Affairs for Oncology and In Vitro Diagnostics, Bayer
![](https://aaadv.org/wp-content/uploads/2022/07/jian-e1686887544917-150x150.jpg)
Jian Wang, PhD
Head of Translational, Oncology Regulatory Science, Strategy & Excellence, AstraZeneca
![](https://aaadv.org/wp-content/uploads/2019/01/H.-Kim_1473789997-2-150x150.jpg)
H. Kim Lyerly, MD, FACS, FSSO
George Barth Gellar Chair, Professor Surgery, Pathology and Immunology, Duke University
![Terrell Baptiste](https://aaadv.org/wp-content/uploads/2022/07/Screen-Shot-2022-07-29-at-11.55.29-AM-e1686865521494-150x150.png)
Terrell Baptiste, MBA
Associate Director, Regulatory Policy and Intelligence, Gilead
![Wendy L. Clemens](https://aaadv.org/wp-content/uploads/2022/08/Screen-Shot-2022-08-02-at-11.31.31-PM-e1659479581237-150x150.png)
Wendy Clemens, PhD
Vice President Early Development Vice President Early Development , Bristol-Myers Squibb